These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 14514745)

  • 1. Protocolized anemia management with erythropoietin in hemodialysis patients: a randomized controlled trial.
    Brimble KS; Rabbat CG; McKenna P; Lambert K; Carlisle EJ
    J Am Soc Nephrol; 2003 Oct; 14(10):2654-61. PubMed ID: 14514745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin.
    Fishbane S; Berns JS
    Kidney Int; 2005 Sep; 68(3):1337-43. PubMed ID: 16105069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients.
    Vanrenterghem Y; Bárány P; Mann JF; Kerr PG; Wilson J; Baker NF; Gray SJ;
    Kidney Int; 2002 Dec; 62(6):2167-75. PubMed ID: 12427142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mathematical approach for estimating iron needs in hemodialysis patients on erythropoietin therapy.
    Tarng DC; Huang TP; Chen TW
    Am J Nephrol; 1997; 17(2):158-64. PubMed ID: 9096447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of subcutaneous and intravenous recombinant human erythropoietin for anemia in hemodialysis patients with significant comorbid disease.
    Muirhead N; Churchill DN; Goldstein M; Nadler SP; Posen G; Wong C; Slaughter D; Laplante P
    Am J Nephrol; 1992; 12(5):303-10. PubMed ID: 1488998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized equivalence study evaluating the possibility of switching hemodialysis patients receiving subcutaneous human erythropoietin directly to intravenous darbepoetin alfa.
    Chazot C; Terrat JC; Dumoulin A; Ang KS; Gassia JP; Chedid K; Maurice F; Canaud B;
    Ann Pharmacother; 2009 Feb; 43(2):228-34. PubMed ID: 19407262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin.
    Hasegawa T; Bragg-Gresham JL; Pisoni RL; Robinson BM; Fukuhara S; Akiba T; Saito A; Kurokawa K; Akizawa T
    Kidney Int; 2011 Feb; 79(3):340-6. PubMed ID: 20962740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Pisoni RL; Bragg-Gresham JL; Young EW; Akizawa T; Asano Y; Locatelli F; Bommer J; Cruz JM; Kerr PG; Mendelssohn DC; Held PJ; Port FK
    Am J Kidney Dis; 2004 Jul; 44(1):94-111. PubMed ID: 15211443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting higher ferritin concentrations with intravenous iron dextran lowers erythropoietin requirement in hemodialysis patients.
    DeVita MV; Frumkin D; Mittal S; Kamran A; Fishbane S; Michelis MF
    Clin Nephrol; 2003 Nov; 60(5):335-40. PubMed ID: 14640239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human erythropoietin treatment of anemia in renal transplant patients.
    Lezaic V; Djukanovic L; Pavlovic-Kentera V
    Ren Fail; 1995 Nov; 17(6):705-14. PubMed ID: 8771243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anemia and carnitine supplementation in hemodialyzed patients.
    Kletzmayr J; Mayer G; Legenstein E; Heinz-Peer G; Leitha T; Hörl WH; Kovarik J
    Kidney Int Suppl; 1999 Mar; 69():S93-106. PubMed ID: 10084293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Darbepoetin-alfa treatment of anemia secondary to chronic renal failure in dialysis patients: Results of a French multicenter study].
    Kessler M; Hannedouche T; Fitte H; Cayotte JL; Urena P; Réglier JC;
    Nephrol Ther; 2006 Sep; 2(4):191-9. PubMed ID: 16966064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients.
    Gaughan WJ; Liss KA; Dunn SR; Mangold AM; Buhsmer JP; Michael B; Burke JF
    Am J Kidney Dis; 1997 Oct; 30(4):495-500. PubMed ID: 9328363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of frequency of intravenous iron administration on hemoglobin variability in maintenance hemodialysis patients.
    Wan L; Zhang D
    Int Urol Nephrol; 2018 Aug; 50(8):1511-1518. PubMed ID: 29946818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialysis patients with the metabolic syndrome need less recombinant human erythropoietin for similar hemoglobin levels.
    Uyar ME; Tutal E; Bal Z; Sezer S
    Transplant Proc; 2013; 45(10):3481-4. PubMed ID: 24314937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients.
    Movilli E; Cancarini GC; Zani R; Camerini C; Sandrini M; Maiorca R
    Nephrol Dial Transplant; 2001 Jan; 16(1):111-4. PubMed ID: 11209002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anemia in peritoneal dialysis patients].
    Lausević M; Nesić V; Jovanović N; Stojimirović B
    Srp Arh Celok Lek; 2006; 134(3-4):133-7. PubMed ID: 16915754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous iron dextran and erythropoietin use in pediatric hemodialysis patients.
    Greenbaum LA; Pan CG; Caley C; Nelson T; Sheth KJ
    Pediatr Nephrol; 2000 Sep; 14(10-11):908-11. PubMed ID: 10975297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of weekly or successive iron supplementation on erythropoietin doses in patients receiving hemodialysis.
    Kato A; Hamada M; Suzuki T; Maruyama T; Maruyama Y; Hishida A
    Nephron; 2001 Sep; 89(1):110-2. PubMed ID: 11528242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.